New York Professional Events List

Breast Imaging from A to Z: Read Like (or Better Than.) the Experts

Sep 09, 2017 - 08:00 AM - Sep 10, 05:00 PM
CME Science
Wyndham New Yorker Hotel
481 8th Avenue,

New York,
ZIP: 10001
Phone: 1-650-440-4424

Ticket Price: Practicing Physician/Industry - USD 1195, Military/Retired - USD 1095, Resident/Fellow/Technologist - USD 795
Session 1 will take the attendee through the histopathologic basis for benign and malignant breast disease with imaging correlates. Conventional topics with simplified and novel strategies are presented to both review and advance the practice of mammography and ultrasound.

Session 2 focuses on imaging diagnoses for which surveillance may be reasonable and will emphasize techniques and analytic parameters regarding intervention and tissue diagnosis.

Session 3 will address the critical issues of breast density risk assessment as well as perspectives on supplementary screening such as whole breast ultrasound and tomosynthesis.

Session 4 explores in depth both current and evolving concepts and strategies in MRI interpretation with review of literature and case based presentation.

Session 5 explores the issues of medical legal accountability in interpretation and communication as well as providing strategies to avoid liability.

By the end of this course, participants should be able to:

1. Analyze the histopathologic basis for benign and malignant breast lesions
2. Analyze more robust and simplified methods of evaluating asymmetries commonly seen at screening and diagnostic settings
3. Assess criteria for imaging diagnoses of benign, probably benign, and suspicious imaging findings on mammography, ultrasound, MRI
4. Assess Criteria For Imaging Diagnoses And Need For Tissue Diagnosis Of Identified Breast Lesions
5. Determine suitability for nonpalpable lesions subject to imaging surveillance as opposed to biopsy
6. Analyze applications, techniques, and pitfalls of stereotactic, ultrasound, and MRI-guided biopsy
7. Evaluate the basis and evidence for recommending surgical excision of “high risk” lesions determined by percutaneous biopsy
8. Analyze current issues involved in breast density evaluation including risk and supplementary screening indications

Booking :

Speakers : R. James Brenner, MD, JD, FACR, FCLM

Event Categories


Events Calendar

27 28 29 30 31 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Event Location


VIP Life Time Subscription to our Newsletters!

Forbes Women's Summit 2018
Disrupt SF 2018 - Brought to you by Techcrunch
U.S. Naval Institute Annual Meeting 2018
Breast Cancer Research Foundation
Children’s Health Fund
The World Energy Engineering Congress (WEEC)
                            Oct. 17-19, 2018
                            Charlotte, NC